Sales rise 18.49% to Rs 8.46 crore
Net profit of Sandu Pharmaceuticals declined 47.62% to Rs 0.11 crore in the quarter ended June 2013 as against Rs 0.21 crore during the previous quarter ended June 2012. Sales rose 18.49% to Rs 8.46 crore in the quarter ended June 2013 as against Rs 7.14 crore during the previous quarter ended June 2012. ParticularsQuarter EndedJun. 2013Jun. 2012% Var.Sales8.467.14 18 OPM %6.037.00 -PBDT0.330.37 -11 PBT0.140.26 -46 NP0.110.21 -48Powered by Capital Market - Live News